James H. Wikel

Director Técnico/Científico/I+D en Apexian Pharmaceuticals, Inc. .

Health Technology

Consumer Services

Perfil

James H.
Wikel is currently the Head of Research & Development at Apexian Pharmaceuticals, Inc. He was previously a Principal at Eli Lilly & Co. from 1971 to 2004 and the Chief Technology Officer at Coalesix, Inc. He received his undergraduate and graduate degrees from Marshall University.

Cargos activos de James H. Wikel

Empresas	Cargo	Inicio
Apexian Pharmaceuticals, Inc. Apexian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Apexian Pharmaceuticals, Inc. discovers, develops and commercializes novel pharmaceuticals products. It offers pharmaceutical products for the treatment of pancreatic cancer, blood cancer, brain tumors, ovarian cancer, age-related macular degeneration, and diabetic retinopathy. The company was founded by Mark R. Kelley in 2005 and is headquartered in Indianapolis, IN.	Director Técnico/Científico/I+D	-

Todos los cargos activos de James H. Wikel

Antiguos cargos conocidos de James H. Wikel.

Empresas	Cargo	Fin
ELI LILLY AND COMPANY	Corporate Officer/Principal	-
Coalesix, Inc.	Director Técnico/Científico/I+D	-

Ver el detalle de la experiencia de James H. Wikel.

Formación de James H. Wikel.

Marshall University

Graduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de James H. Wikel.

Relaciones

100 +

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
ELI LILLY AND COMPANY	Health Technology

Empresas privadas	2
Coalesix, Inc.
Apexian Pharmaceuticals, Inc. Apexian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Apexian Pharmaceuticals, Inc. discovers, develops and commercializes novel pharmaceuticals products. It offers pharmaceutical products for the treatment of pancreatic cancer, blood cancer, brain tumors, ovarian cancer, age-related macular degeneration, and diabetic retinopathy. The company was founded by Mark R. Kelley in 2005 and is headquartered in Indianapolis, IN.	Health Technology